SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015756
Filing Date
2018-11-13
Accepted
2018-11-13 16:16:40
Documents
53
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 492136
2 ex10-1.htm EX-10.1 104044
3 ex31.htm EX-31 34075
4 ex32.htm EX-32 8831
  Complete submission text file 0001493152-18-015756.txt   2912507

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ocx-20180930.xml EX-101.INS 403770
6 XBRL SCHEMA FILE ocx-20180930.xsd EX-101.SCH 36674
7 XBRL CALCULATION FILE ocx-20180930_cal.xml EX-101.CAL 50929
8 XBRL DEFINITION FILE ocx-20180930_def.xml EX-101.DEF 132520
9 XBRL LABEL FILE ocx-20180930_lab.xml EX-101.LAB 267221
10 XBRL PRESENTATION FILE ocx-20180930_pre.xml EX-101.PRE 202032
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 510-775-0515
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37648 | Film No.: 181178173
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1